Differential obesity indices identify the metabolic syndrome in Black men and women in Cape Town: the CRIBSA study

被引:25
作者
Peer, N. [1 ,2 ]
Steyn, K. [3 ]
Levitt, N. [3 ,4 ]
机构
[1] South African Med Res Council, Noncommunicable Dis Res Unit, ZA-4001 Durban, South Africa
[2] Univ Cape Town, Dept Med, ZA-8001 Cape Town, South Africa
[3] Univ Cape Town, Chron Dis Initiat Africa, Dept Med, ZA-8001 Cape Town, South Africa
[4] Univ Cape Town, Div Diabet Med & Endocrinol, Dept Med, ZA-8001 Cape Town, South Africa
基金
英国医学研究理事会;
关键词
Black; BMI; obesity; obesity threshold; South Africa; urban; waist circumference; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; HEIGHT RATIO; RISK;
D O I
10.1093/pubmed/fdu115
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To determine the obesity indices, specifically waist circumference (WC), that identified a parts per thousand yen2 other metabolic syndrome (MS) components (2009 criteria) in 25- to 74-year-old Africans in Cape Town. Data were collected from a cross-sectional sample by administered questionnaires, clinical measurements and biochemical analyses. The obesity cut points were estimated by the Youden Index. Logistic regression analyses determined whether obesity cut points identifying a parts per thousand yen2 MS components occurred at true inflection points. Among the 1099 participants, the calculated cut points and 95% confidence intervals (CI) were: men, WC 83.9 cm (81.6-86.2), waist-to-hip ratio (WHR) 0.89 (0.87-0.90), waist-to-height ratio (WHtR) 0.50 (0.48-0.52) and body mass index (BMI) 24.1 kg/m(2) (22.0-26.1); women, WC 94.0 cm (92.6-95.3), WHR 0.85 (0.83-0.87), WHtR 0.59 (0.57-0.60) and BMI 32.1 kg/m(2) (29.7-34.6). Raised WC was significantly associated with a parts per thousand yen2 MS components in men: WC 84.0-93.9 cm (odds ratio (OR): 3.19, 95% confidence interval (CI): 1.73-5.85) and WC a parts per thousand yen94.0 cm (OR: 8.50, 95% CI: 4.44-16.25) compared with WC < 84.0 cm, and in women: WC 80.0-93.9 cm (OR: 2.93, 95% CI: 1.32-6.54) and WC a parts per thousand yen94.0 cm (OR: 5.33, 95% CI: 2.40-11.85) compared with WC < 80.0 cm. In the logistic model with BMI for women, obesity (OR: 3.60, 95% CI: 1.82-7.10) but not overweight (P = 0.063) was significantly associated with a parts per thousand yen2 MS components. Obesity cut points for Africans should be re-evaluated and adjusted accordingly.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 28 条
[21]   Metabolic syndrome [J].
Opie, Lionel H. .
CIRCULATION, 2007, 115 (03) :E32-E35
[22]   Rising Diabetes Prevalence among Urban-Dwelling Black South Africans [J].
Peer, Nasheeta ;
Steyn, Krisela ;
Lombard, Carl ;
Lambert, Estelle V. ;
Vythilingum, Bavanisha ;
Levitt, Naomi S. .
PLOS ONE, 2012, 7 (09)
[23]   Obesity in South Africa: The South African demographic and health survey [J].
Puoane, T ;
Steyn, K ;
Bradshaw, D ;
Laubscher, R ;
Fourie, J ;
Lambert, V ;
Mbananga, N .
OBESITY RESEARCH, 2002, 10 (10) :1038-1048
[24]   Waist Circumference, BMI, and Visceral Adipose Tissue in White Women and Women of African Descent [J].
Sumner, Anne E. ;
Micklesfield, Lisa K. ;
Ricks, Madia ;
Tambay, Anita V. ;
Avila, Nilo A. ;
Thomas, Francine ;
Lambert, Estelle V. ;
Levitt, Naomi S. ;
Evans, Juliet ;
Rotimi, Charles N. ;
Tulloch-Reid, Marshall K. ;
Goedecke, Julia H. .
OBESITY, 2011, 19 (03) :671-674
[25]  
Taslim S, 2009, ANN ACAD MED SINGAP, V38, P29
[26]   Evaluation of waist-to-height ratio to predict 5 year cardiometabolic risk in sub-Saharan African adults [J].
Ware, L. J. ;
Rennie, K. L. ;
Kruger, H. S. ;
Kruger, I. M. ;
Greeff, M. ;
Fourie, C. M. T. ;
Huisman, H. W. ;
Scheepers, J. D. W. ;
Uys, A. S. ;
Kruger, R. ;
Van Rooyen, J. M. ;
Schutte, R. ;
Schutte, A. E. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (08) :900-907
[27]   Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus [J].
Wilson, PWF ;
D'Agostino, RB ;
Parise, H ;
Sullivan, L ;
Meigs, JB .
CIRCULATION, 2005, 112 (20) :3066-3072
[28]   Metabolic syndrome - Cardiovascular risk assessment and management [J].
Wong, Nathan D. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (04) :259-272